Legal status · United States
Is Lotiglipron legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Lotiglipron is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile.
Lotiglipron in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Phase 2 terminated early for safety reasons. Development discontinued. Not available. |
| FDA approval status | Never approved. The phase 2 programme was terminated early for safety and development did not continue. |
| Human studies cited | 1 of 1 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Lotiglipron profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Lotiglipron is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Lotiglipron is
It worked. 901 participants, HbA1c down 1.44 percent, weight down 7.47 percent against 1.84 on placebo, and the trial was stopped early for safety.
Lotiglipron is the clearest illustration of why an oral GLP-1 pill was harder than it looked, because the problem was never whether it worked. Pfizer ran a phase 2 dose-ranging study in 901 participants across two cohorts, type 2 diabetes and obesity.
Mechanism: A small-molecule agonist at the GLP-1 receptor, taken orally. Unlike semaglutide, which is a peptide requiring an absorption enhancer to survive the gut in tablet form, a small molecule can be absorbed conventionally, which is the entire commercial appeal.
Regulatory history: Never approved. The phase 2 programme was terminated early for safety and development did not continue.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Lotiglipron at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Lotiglipron in other countries
Frequently asked questions
Is Lotiglipron legal in the United States?
No. Lotiglipron is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 1 human study is cited on its profile. Note: Phase 2 terminated early for safety reasons. Development discontinued. Not available.
Can I buy Lotiglipron in the United States?
No approved product exists to buy. In the United States Lotiglipron is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Phase 2 terminated early for safety reasons. Development discontinued. Not available.
Is Lotiglipron FDA approved?
No. FDA status: Never approved. The phase 2 programme was terminated early for safety and development did not continue.. Current US classification: "Not approved; research use only". On the evidence, 1 human study is cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Lotiglipron live on its compound profile.
Lotiglipron profileThis page is general information about the regulatory status of Lotiglipron in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.